Digital biomarkers: Navigating the path from ideation to impact through deep phenotyping in precision medicine

Citation

Gvozdanovic A, Powell D, McKinnell D, Burnett S & Talibi S (2023) Digital biomarkers: Navigating the path from ideation to impact through deep phenotyping in precision medicine. Deloitte Insights. 31.08.2023. https://www2.deloitte.com/uk/en/insights/industry/life-sciences/digital-measurement-and-digital-biomarkers-are-the-future-of-healthcare.html

Abstract
Digital biomarkers herald a new era of precision medicine, bringing operational and clinical benefits to the life sciences industry. But how can a digital measurements strategy best assure regulatory compliance while also demonstrating financial and user value as well as viability?